| |
|
|
|
Innovate Biopharmaceuticals Inc.  
|
|
1.11 0.01 (0.01%) |
07-15 16:00 |
|
Open: |
1.1 |
Pre close: |
1.1 |
Target:
|
1.47
|
|
High: |
1.14 |
Low: |
1.08 |
Resistance:
|
1.26
1.37
|
|
Volume: |
99,097 |
Market Cap: |
39M |
Support:
|
1.07
0.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.12
 |
MACD |
MACD(12,26):
|
-0.05  |
|
MA(20): |
1.14 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
1.60 |
Stochastic Oscillator |
%K(14,3):
|
20.00 |
|
MA(250): |
3.16 |
%D(3): |
25.00 |
|
Average Volume(K) |
3-Month: |
85054
|
52-Week |
High:
|
9.68 |
|
10-Days: |
12275 |
Low: |
1.07 |
|
RSI |
RSI(14):
|
38.82 |
Change(%): |
-86.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.519 |
Return on Equity (ttm) |
-288.2 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-52.0 |
Shares Float (M) |
23.20 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
43.23 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.70 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1810 |
|
Book Value (p.s.) |
0.050 |
EBITDA (p.s.) |
-0.303 |
P/E |
-2.14 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
22.20 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.44 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.81 |
P/CF |
-0.00 |
|
|
|
|
|
|
